Most ReadLiver transplantation is the only effective treatment for various end−stage liver diseases. However, immune injury after liver transplantation, such as acute rejection (AR), chronic rejection (CR), hepatic ischemia−reperfusion injury (HIRI), and opportunistic infection, still seriously affects the prognosis of patients. Although great progress has been made in the research of immune injury after liver transplantation, there are still many deficiencies in clinical practice. In this article, the functional changes of hepatocytes and non−parenchymal cells after liver transplantation were used as the breakthrough point to summarize and clarify the potential molecular mechanisms of immune injury after liver transplantation, systematically review the latest progress in the prevention and treatment of immune injury after liver transplantation, and focus on emerging prevention and treatment strategies and their clinical application prospects. The application of artificial intelligence and big data technology in the prediction, diagnosis, treatment and management of immune injury in liver transplantation is prospected, in order to provide reference for related basic research and clinical application.
Updates
-
22MAYCAST Holds 2026 Exchange and Deployment Activity for Strengthening Organization Construction of University Associations for Science and Technology
-
22MAY2026 Plenary Meeting of the China National Committee for the International Science Council Convened
-
22MAYNotice of the National Press and Publication Administration on Announcing the List of Outstanding Key Laboratories of Science, Technology and Standards in the Publishing Industry for 2025
-
22MAYThe 6th China (Beijing) Radio and Television Media Convergence Development Conference Held
-
22MAYTransformation and Impact of AI-Enabled Academic Publishing
Calls for Papers


Journals









